Smart single hollow magnetothermal nanorings with phase change materials for controlled drug release and negative MRI guided cancer therapy Научная публикация
| Журнал |
International Journal of Pharmaceutics
ISSN: 1873-3476 |
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Вых. Данные | Год: 2026, Том: 700, Номер статьи : 127042, Страниц : 14 DOI: 10.1016/j.ijpharm.2026.127042 | ||||||||||||||||||
| Ключевые слова | Phase change materials; Controlled drug release; Magnetichyperthermia; Magnetic resonance imaging; Theranostics | ||||||||||||||||||
| Авторы |
|
||||||||||||||||||
| Организации |
|
Реферат:
Magnetic hyperthermia therapy (MHT) for tumors is alocalized, minimally invasive, and deeply penetrating treatment, but it faces limitations such as low magnetothermal conversion efficiency, strict safety thresholds for magnetic field intensity, and the inability of single-mode magnetic hyperthermia to completely eradicate tumors. In this work, we develop an innovative, thermoresponsive drug-delivery platform composed of single hollow magnetic vortex iron oxide nanorings (MVIONs) coated with phase-change materials (PCM), designated MVIONs@PCM. Under an alternating magnetic field (AMF), MVIONs efficiently generate heat, triggering the melting of the PCM shell and releasing co-encapsulated anticancer drugs in a controlled, “on/off” manner. In vitro experiments confirm the exceptional thermal induction capacity of MVIONs@PCM, yielding a specific absorption rate of 1058.68 W·g−1 at 600 Oe, sufficient to produce robust hyperthermia effects. Additionally, this nano platform exhibits very low basal release without AMF activation. MVIONs@PCM also achieves strong negative magnetic resonance imaging (MRI) contrast, with a high transverse relaxivity (R2 = 45.986 mM−1·s−1) even at 0.5 T, supporting real-time treatment guidance and monitoring. Combining magnetic hyperthermia and AMF-induced chemotherapy significantly enhances tumor growth inhibition. This multifunctional platform represents a promising strategy for MRI-guided magnetothermal chemotherapy
Библиографическая ссылка:
Bao J.
, Guo S.
, Ren Y.
, Cheng J.
, Yang Y.
, Zhang Y.
, Tu H.
, Wang J.
, Fan D.
, Zhuang Y.
, Dong Y.
, Tulupov A.
, Wang X.
, Ma X.
, Zhang Y.
Smart single hollow magnetothermal nanorings with phase change materials for controlled drug release and negative MRI guided cancer therapy
International Journal of Pharmaceutics. 2026. V.700. 127042 :1-14. DOI: 10.1016/j.ijpharm.2026.127042 WOS Scopus OpenAlex
Smart single hollow magnetothermal nanorings with phase change materials for controlled drug release and negative MRI guided cancer therapy
International Journal of Pharmaceutics. 2026. V.700. 127042 :1-14. DOI: 10.1016/j.ijpharm.2026.127042 WOS Scopus OpenAlex
Даты:
| Поступила в редакцию: | 8 янв. 2026 г. |
| Принята к публикации: | 30 мая 2026 г. |
| Опубликована online: | 4 июн. 2026 г. |
| Опубликована в печати: | 10 июл. 2026 г. |
Идентификаторы БД:
| ≡ Web of science: | WOS:001798920900001 |
| ≡ Scopus: | 2-s2.0-105042046103 |
| ≡ OpenAlex: | W7163565465 |